Previous Close | 3.5700 |
Open | 3.5200 |
Bid | 3.9500 x 100 |
Ask | 4.0700 x 100 |
Day's Range | 3.5000 - 4.0500 |
52 Week Range | 3.2450 - 16.2000 |
Volume | |
Avg. Volume | 60,255 |
Market Cap | 49.431M |
Beta (5Y Monthly) | -0.09 |
PE Ratio (TTM) | 0.93 |
EPS (TTM) | 4.3500 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 60.00 |
Subscribe to Yahoo Finance Plus to view Fair Value for PRE
Prenetics Global Limited (NASDAQ:PRE), a leading genomics-driven health sciences company, announces the signing of a Memorandum of Understanding (MOU), that paves the way for a strategic investment in Metavisionaries and a pioneering five-year research agreement with them and their partners Space Application Services through their Metaspace Venture. The parties will also establish a Space Innovation Lab within the UAE Space Agency. The inaugural Prenetics research cube is scheduled to on-board t
Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading genomics-driven health sciences company, today announced financial results for the third quarter ended September 30, 2023, along with recent business updates.
With the business potentially at an important milestone, we thought we'd take a closer look at Prenetics Global...